Legal & General Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,788
| Closed | -$2.14K | – | 3464 |
|
|
2025
Q1 | $2.14K | Hold |
3,788
| – | – | ﹤0.01% | 3350 |
|
|
2024
Q4 | $7.94K | Hold |
3,788
| – | – | ﹤0.01% | 3290 |
|
|
2024
Q3 | $10.2K | Hold |
3,788
| – | – | ﹤0.01% | 3267 |
|
|
2024
Q2 | $10.8K | Sell |
3,788
-632
| -14% | -$1.8K | ﹤0.01% | 3283 |
|
|
2024
Q1 | $18.7K | Hold |
4,420
| – | – | ﹤0.01% | 2992 |
|
|
2023
Q4 | $23.6K | Buy |
4,420
+405
| +10% | +$2.17K | ﹤0.01% | 2967 |
|
|
2023
Q3 | $17.3K | Sell |
4,015
-714
| -15% | -$3.07K | ﹤0.01% | 3093 |
|
|
2023
Q2 | $26K | Buy |
+4,729
| New | +$26K | ﹤0.01% | 3003 |
|
|
2022
Q2 | – | Sell |
-3,851
| Closed | -$24K | – | 3580 |
|
|
2022
Q1 | $24K | Hold |
3,851
| – | – | ﹤0.01% | 3188 |
|
|
2021
Q4 | $27K | Hold |
3,851
| – | – | ﹤0.01% | 3185 |
|
|
2021
Q3 | $27K | Hold |
3,851
| – | – | ﹤0.01% | 3165 |
|
|
2021
Q2 | $32K | Buy |
3,851
+521
| +16% | +$4.33K | ﹤0.01% | 3111 |
|
|
2021
Q1 | $18K | Hold |
3,330
| – | – | ﹤0.01% | 3170 |
|
|
2020
Q4 | $14K | Hold |
3,330
| – | – | ﹤0.01% | 3219 |
|
|
2020
Q3 | $10K | Sell |
3,330
-1,452
| -30% | -$4.36K | ﹤0.01% | 3232 |
|
|
2020
Q2 | $15K | Buy |
+4,782
| New | +$15K | ﹤0.01% | 3181 |
|
|
2019
Q3 | – | Sell |
-5,226
| Closed | -$10K | – | 3382 |
|
|
2019
Q2 | $10K | Hold |
5,226
| – | – | ﹤0.01% | 3357 |
|
|
2019
Q1 | $23K | Hold |
5,226
| – | – | ﹤0.01% | 3044 |
|
|
2018
Q4 | $17K | Hold |
5,226
| – | – | ﹤0.01% | 3142 |
|
|
2018
Q3 | $27K | Hold |
5,226
| – | – | ﹤0.01% | 3076 |
|
|
2018
Q2 | $28K | Buy |
+5,226
| New | +$28K | ﹤0.01% | 3051 |
|